Bausch + Lomb Launches Preloaded enVista Envy(TM) Full Range of Vision Intraocular Lenses in Europe
N/A
On April 7 2026 Bausch + Lomb announced the European commercial launch of its first diffractive premium intra‑ocular lens, enVista Envy™, delivered preloaded in the EyeGility® system. The IOL provides a continuous range of vision with 0.50 D step increments down to 0.90 D at the IOL plane and enables one‑handed implantation through a ≤2 mm incision with up to 20 minutes standby time. Clinical data from U.S. (332 subjects) and Canadian (110 subjects) studies showed high dysphotopsia tolerance (86.1% little/no glare/halo) and strong near‑vision satisfaction (95.4% little/no difficulty). The launch follows successful introductions in the United States and Canada, marking Bausch + Lomb’s first diffractive premium IOL approved for sale in Europe.
The news represents an incremental but positive step: it expands the enVista platform into a new geography (Europe) where the company previously had no commercial presence for this product line. The launch aligns with prior guidance that Bausch + Lomb would roll out its premium IOL franchise globally after U.S./Canada acceptance. No unexpected financial upside or downside is disclosed; clinical performance mirrors earlier results, and there is no indication of a material shift in revenue expectations relative to the company’s ~$8 billion market cap. Therefore the impact is routine‑positive rather than game‑changing.
Bausch + Lomb Corp. operates as an integrated eye‑care company with three core segments: Vision Care (contact lenses, lens care, ocular health products), Surgical (ophthalmic surgical devices, premium intra‑ocular lenses, laser platforms) and Pharmaceuticals (prescription and OTC ophthalmic drugs). Its flagship project is the enVista® platform of premium intra‑ocular lenses, which now includes the diffractive Envy™ model launched in Europe April 2026. The platform aims to provide a continuous range of vision with minimal dysphotopsia, leveraging proprietary optics and the EyeGility® preloaded delivery system for surgeon efficiency.